Stay updated on Guselkumab in Active PsA: Efficacy & Safety Clinical Trial

Sign up to get notified when there's something new on the Guselkumab in Active PsA: Efficacy & Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Guselkumab in Active PsA: Efficacy & Safety Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    An NIH-wide notice about terminology changes appears above the 403 Forbidden page, and the site revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:34:10.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov study page remains a 403 Forbidden error, while the displayed site revision changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T00:51:17.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study content. This shows the page is currently blocked from access.
    Difference
    20%
    Check dated 2026-09-23T00:46:29.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page's revision tag has been updated to v3.7.0, signaling a newer build of the page. This metadata change does not modify the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-09-15T23:58:00.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    A new site revision tag (Revision: v3.6.6) replaces the previous Revision: v3.6.5, reflecting a minor update to the page infrastructure.
    Difference
    0.0%
    Check dated 2026-09-01T20:07:30.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    A new NIH funding identifier was added to the study’s identifiers: 2014 ( U.S. NIH Grant/Contract ). This addition links the record to NIH-supported funding for the trial, clarifying its funding source.
    Difference
    0.0%
    Check dated 2026-08-25T21:49:45.000Z thumbnail image

Stay in the know with updates to Guselkumab in Active PsA: Efficacy & Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Guselkumab in Active PsA: Efficacy & Safety Clinical Trial page.